Suppr超能文献

皮肤和黏膜的默克尔细胞癌:12例皮肤病例报告,其中2例起源于鼻黏膜。

Merkel cell carcinoma of the skin and mucosa: report of 12 cutaneous cases with 2 cases arising from the nasal mucosa.

作者信息

Snow S N, Larson P O, Hardy S, Bentz M, Madjar D, Landeck A, Oriba H, Olansky D

机构信息

Division of Plastic Surgery, Section of Mohs Surgery, Department of Surgery, University of Wisconsin-Madison, School of Medicine, Madison, Wisconsin 53705, USA.

出版信息

Dermatol Surg. 2001 Feb;27(2):165-70. doi: 10.1046/j.1524-4725.2001.00189.x.

Abstract

BACKGROUND

Merkel cell carcinoma (MCC) is an uncommon skin tumor that most frequently arises on sun-exposed facial sites. It rarely occurs on mucous membranes of the head region. The primary MCC is usually treated by wide excision followed by radiation to the primary site and regional lymph nodes. Using traditional surgery the local recurrence rate ranges from 20 to 50%. In our clinic, Mohs surgery is used to excise the primary MCC completely, followed by radiation. Here we present our treatment experiences and outcomes.

OBJECTIVE

To document our experience of MCC treated by Mohs surgery. We present our series of 12 cases of MCC, 2 cases of which arose from mucosal sites of the nasal cavity.

METHODS

We reviewed 12 cases of MCC from the Mohs clinic database. We also reviewed the literature for cutaneous and mucosal MCC.

RESULTS

There were 12 cases of MCC: 10 cutaneous and 2 mucous. The site distribution of cutaneous MCC was eight on the head, one on the neck, and one on the groin. Of these, nine were treated by Mohs excision. Two patients developed local recurrence following Mohs treatment. The local recurrence rate was 22% (2 of 9). The sites of mucosal MCC were the nasal septum and nasopharynx. One case had a history of previous radiation and developed an MCC 40 years later. This case also demonstrated epidermotropic spread of Merkel cells to the overlying mucous epithelium. This patient required extensive intranasal and cranial surgery to remove the tumor. Both patients with mucosal MCCs died of their disease. The overall mucocutaneous survival of MCC at 1 year was 80% and at 2 years was 50%.

CONCLUSION

In our series, local control of the primary MCC was achieved in 70% of patients (7 of 10) using combined Mohs excision and radiation. Two recurrences had primary tumors larger than 3.5 cm in diameter, while the other case was nonresectable by Mohs surgery. Tumor size appeared to determine the degree of local control. When the postoperative Mohs defect was less than 3.0 cm in diameter, local and regional control appeared to be more favorable. When the primary facial MCC is relatively small, removal by Mohs surgery followed by radiation was effective, therapeutic, and less disfiguring. Mucosal MCC is rare and may occur as a long-term sequelae after radiation therapy to the skin.

摘要

背景

默克尔细胞癌(MCC)是一种罕见的皮肤肿瘤,最常发生于面部阳光暴露部位。极少发生于头部区域的黏膜。原发性MCC通常采用广泛切除,随后对原发部位和区域淋巴结进行放疗。采用传统手术,局部复发率为20%至50%。在我们诊所,采用莫氏手术完全切除原发性MCC,随后进行放疗。在此,我们介绍我们的治疗经验和结果。

目的

记录我们采用莫氏手术治疗MCC的经验。我们报告了12例MCC病例系列,其中2例起源于鼻腔黏膜部位。

方法

我们回顾了莫氏诊所数据库中的12例MCC病例。我们还查阅了有关皮肤和黏膜MCC的文献。

结果

共有12例MCC:10例为皮肤型,2例为黏膜型。皮肤型MCC的部位分布为8例在头部,1例在颈部,1例在腹股沟。其中,9例采用莫氏切除术治疗。2例患者在莫氏治疗后出现局部复发。局部复发率为22%(9例中的2例)。黏膜型MCC的部位为鼻中隔和鼻咽部。1例患者既往有放疗史,40年后发生MCC。该病例还显示默克尔细胞向覆盖的黏膜上皮的亲表皮性播散。该患者需要进行广泛的鼻内和颅骨手术以切除肿瘤。2例黏膜型MCC患者均死于该病。MCC的总体黏膜皮肤1年生存率为80%,2年生存率为50%。

结论

在我们的病例系列中,70%的患者(10例中的7例)采用莫氏切除联合放疗实现了原发性MCC的局部控制。2例复发患者的原发性肿瘤直径大于3.5 cm,而另一例无法通过莫氏手术切除。肿瘤大小似乎决定了局部控制的程度。当术后莫氏缺损直径小于3.0 cm时,局部和区域控制似乎更理想。当原发性面部MCC相对较小时,采用莫氏手术切除后放疗是有效、有治疗作用且较少毁容的。黏膜型MCC罕见,可能作为皮肤放疗后的长期后遗症出现。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验